Elanco Animal Health Inc (ELAN)

$17.90 +0.11 (0.62%)
Market Cap 8.84B
Revenue (ttm) 4.44B
Net Income (ttm) 338.00M
EPS (ttm) N/A
PE Ratio 19.90
Forward PE 20.33
Profit Margin 7.61%
Debt to Equity Ratio 0.62
Volume 3,129,400
Avg Vol 5,451,952
Day's Range N/A - N/A
Shares Out 496.81M
Stochastic %K 76%
Beta 1.66
Analysts Strong Sell
Price Target $18.44

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Crede...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 877 352 6261
Address:
2500 Innovation Way, Greenfield, United States
MiFIDInvestmentGroup
MiFIDInvestmentGroup Aug. 23 at 1:20 PM
$ELAN Elanco Animal Health Incorporated is facing product portfolio challenges and debt concerns
0 · Reply
chart_thirst
chart_thirst Aug. 21 at 12:22 PM
$ELAN Elanco Animal Health Incorporated is a pure-play animal health company. It is working through operational challenges and a high debt load from its acquisition of Bayer's animal health unit. The stock is a speculative turnaround story in a defensive industry.
0 · Reply
stockpicker63
stockpicker63 Aug. 15 at 6:04 PM
Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.
1 · Reply
NNNTrader
NNNTrader Aug. 15 at 2:08 PM
$ELAN Scored high Tier 1 in my model. Breaking out on all time frames. I'm long.
0 · Reply
Estimize
Estimize Aug. 13 at 10:00 AM
Wall St is expecting 0.13 EPS for $ELAN Q3 [Reporting 11/11 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co
0 · Reply
victorgn
victorgn Aug. 12 at 3:27 PM
$ELAN Amazing stock tg: $19
0 · Reply
boyplunger79
boyplunger79 Aug. 12 at 3:59 AM
$ELAN got the look
0 · Reply
stockpicker63
stockpicker63 Aug. 11 at 1:57 PM
Stocks to watch now! $COLL and $ELAN
0 · Reply
Jblack500
Jblack500 Aug. 11 at 1:47 PM
$GENI $NBIS $ZTS $ELAN added 3 new names this morning. Zts bottomed (215 target from piper...another animal health with earnings momentum ELAN and a chart turnaround....nbis...geni still strong for 2nd half
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 12:30 PM
Piper Sandler updates rating for Elanco Animal Health ( $ELAN ) to Neutral, target set at 12 → 18.
0 · Reply
Latest News on ELAN
Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

Aug 26, 2025, 6:15 PM EDT - 8 hours ago

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

BRKL

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 8:00 AM EDT - 18 hours ago

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:52 PM EDT - 19 days ago

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

Aug 7, 2025, 5:33 PM EDT - 19 days ago

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Aug 7, 2025, 12:23 PM EDT - 19 days ago

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Reports Second Quarter 2025 Results

Aug 7, 2025, 6:27 AM EDT - 19 days ago

Elanco Animal Health Reports Second Quarter 2025 Results

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Jul 24, 2025, 5:42 PM EDT - 4 weeks ago

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Jul 10, 2025, 8:00 AM EDT - 6 weeks ago

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 10:01 AM EDT - 6 weeks ago

Elanco's dog flu vaccine gets USDA nod

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Jul 9, 2025, 8:27 AM EDT - 6 weeks ago

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Jul 2, 2025, 7:09 PM EDT - 7 weeks ago

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Jun 26, 2025, 2:38 PM EDT - 2 months ago

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Elanco Releases 2024 Impact Report and Introduces New Framework

Jun 26, 2025, 1:00 PM EDT - 2 months ago

Elanco Releases 2024 Impact Report and Introduces New Framework

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Jun 12, 2025, 4:17 PM EDT - 2 months ago

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

Jun 5, 2025, 7:45 AM EDT - 2 months ago

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

May 28, 2025, 7:25 AM EDT - 3 months ago

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

Elanco to Participate in the Upcoming Investor Conferences

May 16, 2025, 8:00 AM EDT - 3 months ago

Elanco to Participate in the Upcoming Investor Conferences

Elanco: Deleveraging Takes Time

May 12, 2025, 4:26 AM EDT - 3 months ago

Elanco: Deleveraging Takes Time

Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:52 PM EDT - 3 months ago

Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

May 7, 2025, 11:03 AM EDT - 3 months ago

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

Elanco Animal Health Reports First Quarter 2025 Results

May 7, 2025, 6:27 AM EDT - 3 months ago

Elanco Animal Health Reports First Quarter 2025 Results

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect

May 6, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

May 5, 2025, 4:40 PM EDT - 4 months ago

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

BX

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

May 5, 2025, 6:27 AM EDT - 4 months ago

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

TARS

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

May 4, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

May 1, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 29, 2025, 10:00 AM EDT - 4 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 24, 2025, 10:00 AM EDT - 4 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

Apr 23, 2025, 1:16 PM EDT - 4 months ago

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

ZTS

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect

Apr 22, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Apr 22, 2025, 8:27 AM EDT - 4 months ago

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation

Apr 20, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation

Apr 17, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect

Apr 15, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 13, 2025, 10:00 AM EDT - 4 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Apr 10, 2025, 8:00 AM EDT - 4 months ago

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out

Apr 6, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation

Mar 30, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation

Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets

Mar 17, 2025, 4:17 PM EDT - 5 months ago

Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out

Mar 4, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff

Feb 25, 2025, 1:38 PM EST - 6 months ago

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff

Elanco Animal Health Incorporated (ELAN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 10:59 AM EST - 6 months ago

Elanco Animal Health Incorporated (ELAN) Q4 2024 Earnings Call Transcript

Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle

Feb 25, 2025, 7:05 AM EST - 6 months ago

Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle

Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results

Feb 25, 2025, 7:05 AM EST - 6 months ago

Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results

Elanco to Participate in Upcoming Investor Conferences

Feb 21, 2025, 8:00 AM EST - 6 months ago

Elanco to Participate in Upcoming Investor Conferences

Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness

Feb 20, 2025, 8:27 AM EST - 6 months ago

Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness

Elanco Reinforces Commitment to Veterinary and Pet Owner Education

Feb 13, 2025, 4:29 PM EST - 6 months ago

Elanco Reinforces Commitment to Veterinary and Pet Owner Education

MiFIDInvestmentGroup
MiFIDInvestmentGroup Aug. 23 at 1:20 PM
$ELAN Elanco Animal Health Incorporated is facing product portfolio challenges and debt concerns
0 · Reply
chart_thirst
chart_thirst Aug. 21 at 12:22 PM
$ELAN Elanco Animal Health Incorporated is a pure-play animal health company. It is working through operational challenges and a high debt load from its acquisition of Bayer's animal health unit. The stock is a speculative turnaround story in a defensive industry.
0 · Reply
stockpicker63
stockpicker63 Aug. 15 at 6:04 PM
Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.
1 · Reply
NNNTrader
NNNTrader Aug. 15 at 2:08 PM
$ELAN Scored high Tier 1 in my model. Breaking out on all time frames. I'm long.
0 · Reply
Estimize
Estimize Aug. 13 at 10:00 AM
Wall St is expecting 0.13 EPS for $ELAN Q3 [Reporting 11/11 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co
0 · Reply
victorgn
victorgn Aug. 12 at 3:27 PM
$ELAN Amazing stock tg: $19
0 · Reply
boyplunger79
boyplunger79 Aug. 12 at 3:59 AM
$ELAN got the look
0 · Reply
stockpicker63
stockpicker63 Aug. 11 at 1:57 PM
Stocks to watch now! $COLL and $ELAN
0 · Reply
Jblack500
Jblack500 Aug. 11 at 1:47 PM
$GENI $NBIS $ZTS $ELAN added 3 new names this morning. Zts bottomed (215 target from piper...another animal health with earnings momentum ELAN and a chart turnaround....nbis...geni still strong for 2nd half
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 12:30 PM
Piper Sandler updates rating for Elanco Animal Health ( $ELAN ) to Neutral, target set at 12 → 18.
0 · Reply
CrimsonBullMD
CrimsonBullMD Aug. 11 at 11:51 AM
$ELAN outperforming general market, consol breakout with volume on positive earnings
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 4:20 PM
UBS has adjusted their stance on Elanco Animal Health ( $ELAN ), setting the rating to Buy with a target price of 18 → 19.
0 · Reply
Spicy_Trade
Spicy_Trade Aug. 8 at 3:52 AM
SpicyTrade Elanco Animal Health Incorporat ( $ELAN ) daily stock analysis https://youtu.be/gtaTBbU6V0I?si=tZreWYTxNXtXKIQ1
0 · Reply
henrystevns99
henrystevns99 Aug. 7 at 3:44 PM
$ELAN
0 · Reply
Terrordomo80
Terrordomo80 Aug. 7 at 12:26 PM
$ELAN I only wanna know when this stock is gonna be over 18...it has sat below this level for over a year now despite ER beats on the top and bottom line...its pure insanity and should be investigated by the sec...
0 · Reply
Armymike1981
Armymike1981 Aug. 7 at 12:17 PM
$ELAN FDA accepted Removal of fatal induced risk language from box within 60 days, made public in Q4! This is because zenrelia is better and safer than apoquil. $ZTS sucks
0 · Reply
DonCorleone77
DonCorleone77 Aug. 7 at 10:44 AM
$ELAN Elanco reports Q2 adjusted EPS 26c, consensus 20c -- Q2 revenue $1.24B, consensus $1.19B. -- Raises FY25 adjusted EPS view to 85c-91c from 80c-86c, consensus 84c -- Raises FY25 revenue view to $4.57B-$4.62B from $4.51B-$4.58B, consensus $4.54B. -- Raises FY25 adjusted EBITDA view to $850M-$890M from $830M-$870M.
0 · Reply
OptionWinners
OptionWinners Aug. 5 at 8:52 PM
📢 $ZTS Q2 Earnings Recap Zoetis delivered another strong quarter, beating on both top & bottom lines and raising guidance 🐶💊 💰 EPS: $1.76 vs $1.61 est → ✅ Beat by $0.15 📊 Revenue: $2.50B (+4.2% Y/Y) vs $2.41B est → ✅ Beat by $90M 📆 FY25 Guidance Raised: Revenue: $9.45B–$9.60B (was $9.43B–$9.58B) Adj. EPS: $6.30–$6.40 (was $6.20–$6.30) Organic Revenue Growth: 6.5%–8.0% Organic Adj. Net Income Growth: 5.5%–7.5% 💡 Growth led by Simparica (+17% operational), Key Dermatology (+11%), while Librela saw declines but remains a long-term focus. Shares got a boost as Zoetis continues to show broad-based strength and margin expansion 📈 #Zoetis #ZTS #Earnings #AnimalHealth #PetCare #Pharma #StockMarket #Investing #EarningsSeason #Elanco $ELAN #Idexx $IDXX #Pfizer $PFE
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 25 at 11:31 AM
$ELAN (+3.0% pre) Elanco receives EU approval for canine dermatitis drug Zenrelia https://ooc.bz/l/71197
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 7:09 PM
UBS updates rating for Elanco Animal Health ( $ELAN ) to Buy, target set at 17 → 18.
0 · Reply
JarvisFlow
JarvisFlow Jul. 17 at 12:00 PM
Leerink Partners updates rating for Elanco Animal Health ( $ELAN ) to Outperform, target set at 18.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 3 at 10:56 AM
WATCHLIST JUL 03 2025. $STZ Needham Maintains Buy on Constellation Brands, Raises Price Target to $200 $ELAN Stifel Maintains Buy on Elanco Animal Health, Raises Price Target to $17 $TM Toyota Motor North America Invests More Than $50M In Construction Of New Amenities For Vehicle And Automotive Technology Testing And Development, Affirming Commitment To The Arizona Proving Grounds $WINT Windtree Therapeutics shares are trading higher after the company announced it was issued an istaroxime patent for the United States for Acute Heart Failure. $CRBG KNOT Offshore Partners shares are trading higher after the company announced that it will acquire the Daqing Knutsen from Knutsen NYK Offshore Tankers AS.
0 · Reply